Ten-year results of the Oregon program with 295 consecutive heart transplants in the Pacific Northwest

American Journal of Surgery

Volumn 173, Issue 5, 1997, Pages 426-430

  Cobanoglu, Adnan ^a   Lampros, Thomas ^a   Hershberger, Ray ^a   Norman, Douglas ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CEREBROVASCULAR DISEASE; CHILD; CONGENITAL HEART DISEASE; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SURGICAL MORTALITY; SURVIVAL RATE; UNITED STATES; VALVULAR HEART DISEASE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; NORTHWESTERN UNITED STATES; OREGON; PROSPECTIVE STUDIES;

EID: 0030993189     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(97)00080-9     Document Type: Article

References (19)

1. Lower RR, Shumway NE. Studies on orthotopic transplantation of the canine heart. Surg Forum. 1960;11:18-20.
2. Hosenpud JD, Novick RJ, Bennett LE, et al. The registry of the International Society for Heart and Lung Transplantation. Thirteenth official report - 1996. J Heart Lung Transplant. 1996; 15:655-674.
3. UNOS 1995 Annual report of the U.S. registry of Transplant Recipient and The Organ Procurement and Transplantation Network, Transplant Data 1988-1994. Network for Organ Sharing, Richmond, VA and the Division of Transplantation, Bureau of Health Resources Development, Health Resources and Services Administration, U.S. Department of Health and Human Services, Rockville, MD.
4. Starnes VA, Dyer PE, Stinson EB, et al. Prophylactic OKT 3 used as induction therapy for heart transplantation. Circulation. 1989;80(Suppl III):III-79-III-83.
5. Oh CS, Stratta RJ, Fox BC, et al. Increased infections associated with the use of OKT 3 for treatment of steroid-resistant rejection in renal transplantation. Transplantation. 1988;45:68-73.
6. Kormos RL, Thompson M, Hardesty R, et al. Utility of preoperative right heart catheterization data as a predictor of survival after heart transplantation. J Heart Transplant. 1986;5:391.
7. Kirklin JK, Naftel DC, Kirklin JW, et al. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant. 1988;7:331-336.
8. Smart FW, Naftel DC, Costanzo MR, et al. Risk factors for early cumulative and fatal infections after heart transplantation: a multiinstitutional study. J Heart Lung Transplant. 1996;15:329-341.
9. Johnson DE, Alderman EL, Schroeder JS, et al. Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J Am Cull Cardiol. 1991;17:449-457.
10. Johnson DE, Gao SZ, Schroeder J, et al. The spectrum of coronary artery pathologic findings in human cardiac allogratts. J Heart Transplant. 1989;8:349-359.
11. Ensley RD, Hunt S, Taylor DO, et al. Predictors of survival after repeat heart transplantation. J Heart Lung Transplant. 1992;11:S142-158.
12. Gao S-Z, Schroeder JS, Hunt S, Stinson EB. Re-transplantation tor severe accelerated coronary artery disease in heart transplant recipients. Am J Cardiol. 1988;62:876-886.
13. Penn I. Cancers following cyclosporine therapy. Transplantation. 1987;43:32-35.
14. Evans RW, Orians CE, Archer NL. The potential supply of organ donors: an assessment of the efficiency of organ procurement efforts in the United States. JAMA. 1992;267:239-246.
15. Orians CE, Evans RW, Ascher NL. Estimate of organ-specific donor availability for the United States. Transplant Proc. 1993;25:1541-1542.
16. Ott GY, Hershherger RE, Ratkovec RR, et al. Cardiac allografts from high-risk donors: excellent clinical results. Ann Thorac Surg. 1994;57:76-82.
17. Oakley RME, Yonan NA, Simpson BM, Deiraniya AK. Extended criteria tor cardiac allograft donors: a concensus study. J Heart Lung Transplant. 1996;15:255-259.
18. Lin SS, Platt JL. Immunologic barriers to xenotransplantation. J Heart Lung Transplant. 1996;15:547-555.
19. Michler RE, Shah AS, Itescu S, et al. The influence of concordant xenografts on the humoral and cell-mediated immune responses to subsequent allografts in primates. J Thorac Cardiovasc Surg. 1996;112:1002-1009.